128 related articles for article (PubMed ID: 31603090)
1. Market mapping and landscape analysis of human rabies biologicals in India.
Sudarshan MK; Ashwath Narayana DH; Jayakrishnappa MB
Indian J Public Health; 2019 Sep; 63(Supplement):S37-S43. PubMed ID: 31603090
[TBL] [Abstract][Full Text] [Related]
2. Assessment of procurement, distribution, availability, and utilization of rabies biologicals for postexposure prophylaxis in seven states of India.
D Hanumanthaiah AN; Haradanhalli RS
Indian J Public Health; 2019 Sep; 63(Supplement):S31-S36. PubMed ID: 31603089
[TBL] [Abstract][Full Text] [Related]
3. Background paper for developing a policy for the use of rabies biologicals and vaccination of humans in India.
Sudarshan MK; Ashwath Narayana DH
Indian J Public Health; 2019 Sep; 63(Supplement):S51-S53. PubMed ID: 31603093
[TBL] [Abstract][Full Text] [Related]
4. Facilities and services of postexposure prophylaxis in anti-rabies clinics: A national assessment in India.
Sudarshan MK; Haradanhalli RS
Indian J Public Health; 2019 Sep; 63(Supplement):S26-S30. PubMed ID: 31603088
[TBL] [Abstract][Full Text] [Related]
5. Health-seeking behavior and compliance to post exposure prophylaxis among animal bite victims in India.
Haradanhalli RS; Anwith HS; Pradeep BS; Isloor S; Bilagumba G
Indian J Public Health; 2019 Sep; 63(Supplement):S20-S25. PubMed ID: 31603087
[TBL] [Abstract][Full Text] [Related]
6. A multicentric community survey on animal exposures among humans in India.
Ramesh Masthi NR; Pradeep BS; Bilagumba G
Indian J Public Health; 2019 Sep; 63(Supplement):S9-S14. PubMed ID: 31603085
[TBL] [Abstract][Full Text] [Related]
7. Global characteristics of the rabies biologics market in 2017.
Ives A; Dieuzy-Labaye I; Abela-Ridder B
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A73-A76. PubMed ID: 30420115
[TBL] [Abstract][Full Text] [Related]
8. Fox rabies in India.
Wilde H
Clin Infect Dis; 2005 Feb; 40(4):614-5. PubMed ID: 15712087
[No Abstract] [Full Text] [Related]
9. Epidemiology of animal bites and rabies cases in India. A multicentric study.
Ichhpujani RL; Mala C; Veena M; Singh J; Bhardwaj M; Bhattacharya D; Pattanaik SK; Balakrishnan N; Reddy AK; Samnpath G; Gandhi N; Nagar SS; Shiv L
J Commun Dis; 2008 Mar; 40(1):27-36. PubMed ID: 19127666
[TBL] [Abstract][Full Text] [Related]
10. Cost of rabies post exposure prophylaxis in different healthcare settings in six states of India.
Haradanhalli RS; D Hanumanthaiah AN; Varadappa ST
Indian J Public Health; 2019 Sep; 63(Supplement):S44-S47. PubMed ID: 31603091
[TBL] [Abstract][Full Text] [Related]
11. Using a modified rabies immunoglobulin protocol in a crisis of unavailability: Ethical and practical challenges.
Bharti OK
Indian J Med Ethics; 2019; 4(2):139-143. PubMed ID: 31271357
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of Rabies Postexposure Prophylaxis in Greece: 4 Years Experience.
Dougas G; Konte V; Mitrou K; Georgakopoulou T; Baka A; Liona A; Tatsiou D; Metallidis S; Istikoglou I; Christodoulou E; Stavrakakis M; Pargiana C; Tsalikoglou F; Tzani M; Korou LM; Tasioudi K; Mavrouli M; Vrioni G; Tsiodras S
Vector Borne Zoonotic Dis; 2019 Apr; 19(4):295-301. PubMed ID: 30251935
[TBL] [Abstract][Full Text] [Related]
13. Rabies Postexposure Prophylaxis for Travelers Injured by Nonhuman Primates, Marseille, France, 2001-2014.
Blaise A; Parola P; Brouqui P; Gautret P
Emerg Infect Dis; 2015 Aug; 21(8):1473-6. PubMed ID: 26196180
[TBL] [Abstract][Full Text] [Related]
14. Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures - an exploratory study.
Haradanhalli RS; Kumari N; Sudarshan MK; Narayana DHA; Prashanth RM; Surendran J
Hum Vaccin Immunother; 2021 Dec; 17(12):5355-5360. PubMed ID: 35061550
[TBL] [Abstract][Full Text] [Related]
15. Post-exposure prophylaxis against rabies at two newly designated intradermal rabies vaccination clinics in Kerala, India.
J TM; Mathew T; S AT; M SC; Philip RR
Natl Med J India; 2012; 25(5):268-70. PubMed ID: 23448625
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and surveillance of human animal-bite injuries and rabies post-exposure prophylaxis, in selected counties in Kenya, 2011-2016.
Ngugi JN; Maza AK; Omolo OJ; Obonyo M
BMC Public Health; 2018 Aug; 18(1):996. PubMed ID: 30092769
[TBL] [Abstract][Full Text] [Related]
17. A data platform to improve rabies prevention, Sri Lanka.
De Silva AP; Harischandra PL; Beane A; Rathnayaka S; Pimburage R; Wijesiriwardana W; Gamage D; Jayasinghe D; Sigera C; Gunasekara A; Cadre M; Amunugama S; Athapattu PL; Jayasinghe KSA; Dondorp AM; Haniffa R
Bull World Health Organ; 2017 Sep; 95(9):646-651. PubMed ID: 28867845
[TBL] [Abstract][Full Text] [Related]
18. Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya.
Wambura G; Mwatondo A; Muturi M; Nasimiyu C; Wentworth D; Hampson K; Bichanga P; Tabu C; Juma S; Ngere I; Thumbi SM
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A28-A34. PubMed ID: 31326251
[TBL] [Abstract][Full Text] [Related]
19. Should travellers to rabies-endemic countries be pre-exposure vaccinated? An assessment of post-exposure prophylaxis and pre-exposure prophylaxis given to Danes travelling to rabies-endemic countries 2000-12.
Christiansen AH; Rodriguez AB; Nielsen J; Cowan SA
J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27147729
[TBL] [Abstract][Full Text] [Related]
20. Rabies epidemiology and control in India: a review.
Acharya AS; Kaur R; Lakra K
J Commun Dis; 2012 Jun; 44(2):59-69. PubMed ID: 25151750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
